Related Experiment Video
Updated: Jun 10, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
eNODAL: an experimentally guided nutriomics data clustering method to unravel complex drug-diet interactions
Xiangnan Xu1, Alistair M Senior2,3,4, David G Le Couteur2,5,6
1Chair of Statistics, Humboldt-Universität zu Berlin, Unter den Linden 6, Berlin 10178, Germany.
Briefings in Bioinformatics
|February 21, 2025
Summary
Analyzing complex nutriomics data is challenging. We developed experiment-guided NutriOmics DatA cLustering (eNODAL), a novel method combining ANOVA and clustering to reveal nutrient-drug interactions and improve personalized nutrition insights.
Area of Science:
- Nutritional physiology and personalized medicine
- High-dimensional data analysis in biological systems
Background:
- Nutrient-drug interactions significantly impact health span, necessitating advanced analytical methods.
- Current "omics" data analysis struggles with high dimensionality and complex experimental designs, often missing key biological signals.
- Existing correlation-based methods for nutriomics data analysis yield clusters that are difficult to interpret.
Purpose of the Study:
- To introduce a novel, hybrid framework named experiment-guided NutriOmics DatA cLustering (eNODAL) for analyzing high-dimensional nutriomics data.
- To overcome the limitations of current analytical strategies by integrating experimental design information.
- To enhance the interpretation of complex interactions between nutrients and drugs in biological systems.
Main Methods:
- eNODAL employs a three-step hybrid approach combining Analysis of Variance (ANOVA)-type tests with unsupervised learning.
- Step 1: Categorizes "omics" features into biologically relevant groups based on experimental variable responses using an ANOVA-like test.
- Step 2 & 3: Utilizes consensus clustering within groups to identify subclusters and annotates them using experimental responses and pathway enrichment analysis.
Main Results:
- eNODAL successfully categorizes "omics" features, identifying main effects and interactions of nutritional interventions and drug exposures.
- Consensus clustering within these categories refines the identification of features with similar response profiles.
- The method was validated using mouse data, demonstrating its capability to analyze nutrient-drug interactions relevant to aging mechanisms.
Conclusions:
- eNODAL provides a robust framework for extracting meaningful biological insights from complex, high-dimensional nutriomics experiments.
- This approach enhances the understanding of nutrient-drug interactions, paving the way for advancements in personalized nutrition and human health span.
- eNODAL's ability to integrate experimental design with data-driven clustering offers a significant improvement over traditional correlation-based methods.
More Related Videos
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Related Concept Videos
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...